| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | +4.21% | +0.12% | +4.09% | +4.09% | — |
| 14d | 2 | +50.00% | -1.99% | -0.34% | -1.65% | -1.65% | — |
| 30d | 2 | +50.00% | -4.43% | +0.60% | -5.04% | -5.04% | — |
| 60d | 2 | +50.00% | -6.87% | -0.65% | -6.22% | -6.22% | — |
| 90d | 2 | +50.00% | -8.43% | +5.33% | -13.76% | -13.76% | — |
| 180d | 2(1 pending) | +100.00% | -54.40% | +11.73% | -66.12% | -66.12% | — |
| 1y | 2(1 pending) | +100.00% | -68.54% | +19.93% | -88.48% | -88.48% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AKBA AKEBIA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 56,019 | $1.11 | $62.2K | 616,616 | Jun 29, 2026 | Jul 1, 2026 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 34,951 | $1.39 | $48.6K | 672,635 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 204,000 | — | — | 707,586 | Jan 30, 2026 | Feb 3, 2026 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 320,000 | — | — | 320,000 | Jan 30, 2026 | Feb 3, 2026 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 41,314 | $3.67 | $151.6K | 503,586 | Jun 30, 2025 | Jul 1, 2025 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 292,300 | — | — | 292,300 | Jan 31, 2025 | Feb 4, 2025 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 194,900 | — | — | 544,900 | Jan 31, 2025 | Feb 4, 2025 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 500,000 | Jun 28, 2024 | Jul 2, 2024 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 350,000 | Jun 28, 2024 | Jul 2, 2024 ↗ | View → |